This Article Full Text Full Text (PDF) Purchase Article View Shopping Cart Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Ward, J. A. Articles by Toole, B. P. Search for Related Content PubMed PubMed Citation Articles by Ward, J. A. Articles by Toole, B. P.

(American Journal of Pathology. 2003;162:1403-1409.)
© 2003 American Society for Investigative Pathology

Short Communications

Perturbation of Hyaluronan Interactions Inhibits Malignant Properties of Glioma Cells

From the Department of Anatomy and Cellular Biology, Tufts University School of Medicine, Boston, Massachusetts

Malignant progression of gliomas is characterized by acquisition of inappropriate growth and invasive properties. In vitro, these malignant properties are reflected in, and measured by, the ability to grow in an anchorage-independent manner and to invade artificial extracellular matrices. The results of numerous studies have suggested that the extracellular and pericellular matrix polysaccharide, hyaluronan, plays an important role in these attributes of malignant cancer cells. However, with respect to glioma cells, most studies have addressed the effect of exogenously added hyaluronan rather than the function of endogenous tumor cell-associated hyaluronan. In this study we manipulate hyaluronan-glioma cell interactions by two methods. The first is administration of small hyaluronan oligosaccharides that compete for endogenous hyaluronan polymer interactions, resulting in attenuation of hyaluronan-induced signaling. The second is overexpression of soluble hyaluronan-binding proteins that act as a competitive sink for interaction with endogenous hyaluronan, again leading to attenuated signaling. We find that both treatments inhibit anchorage-independent growth, as measured by colony formation in soft agar, and invasiveness, as measured by penetration of reconstituted basement membrane matrices. Based on our findings, we conclude that endogenous hyaluronan interactions are essential for these two fundamental malignant properties of glioma cells.

This article has been cited by other articles:

				A. G. Gilg, S. L. Tye, L. B. Tolliver, W. G. Wheeler, R. P. Visconti, J. D. Duncan, F. V. Kostova, L. N. Bolds, B. P. Toole, and B. L. Maria Targeting Hyaluronan Interactions in Malignant Gliomas and Their Drug-Resistant Multipotent Progenitors Clin. Cancer Res., March 15, 2008; 14(6): 1804 - 1813. [Abstract] [Full Text] [PDF]

				A. G. Bharadwaj, K. Rector, and M. A. Simpson Inducible Hyaluronan Production Reveals Differential Effects on Prostate Tumor Cell Growth and Tumor Angiogenesis J. Biol. Chem., July 13, 2007; 282(28): 20561 - 20572. [Abstract] [Full Text] [PDF]

				K. Hosono, Y. Nishida, W. Knudson, C. B. Knudson, T. Naruse, Y. Suzuki, and N. Ishiguro Hyaluronan Oligosaccharides Inhibit Tumorigenicity of Osteosarcoma Cell Lines MG-63 and LM-8 in Vitro and in Vivo via Perturbation of Hyaluronan-Rich Pericellular Matrix of the Cells Am. J. Pathol., July 1, 2007; 171(1): 274 - 286. [Abstract] [Full Text] [PDF]

				M. A. Simpson Concurrent Expression of Hyaluronan Biosynthetic and Processing Enzymes Promotes Growth and Vascularization of Prostate Tumors in Mice Am. J. Pathol., July 1, 2006; 169(1): 247 - 257. [Abstract] [Full Text] [PDF]

				S. Misra, S. Ghatak, and B. P. Toole Regulation of MDR1 Expression and Drug Resistance by a Positive Feedback Loop Involving Hyaluronan, Phosphoinositide 3-Kinase, and ErbB2 J. Biol. Chem., May 27, 2005; 280(21): 20310 - 20315. [Abstract] [Full Text] [PDF]

				S. Ghatak, S. Misra, and B. P. Toole Hyaluronan Constitutively Regulates ErbB2 Phosphorylation and Signaling Complex Formation in Carcinoma Cells J. Biol. Chem., March 11, 2005; 280(10): 8875 - 8883. [Abstract] [Full Text] [PDF]

				M.-S. Kim, M.-J. Park, E.-J. Moon, S.-J. Kim, C.-H. Lee, H. Yoo, S.-H. Shin, E.-S. Song, and S.-H. Lee Hyaluronic Acid Induces Osteopontin via the Phosphatidylinositol 3-Kinase/Akt Pathway to Enhance the Motility of Human Glioma Cells Cancer Res., February 1, 2005; 65(3): 686 - 691. [Abstract] [Full Text] [PDF]

				E. A. Marieb, A. Zoltan-Jones, R. Li, S. Misra, S. Ghatak, J. Cao, S. Zucker, and B. P. Toole Emmprin Promotes Anchorage-Independent Growth in Human Mammary Carcinoma Cells by Stimulating Hyaluronan Production Cancer Res., February 15, 2004; 64(4): 1229 - 1232. [Abstract] [Full Text] [PDF]

				A. Zoltan-Jones, L. Huang, S. Ghatak, and B. P. Toole Elevated Hyaluronan Production Induces Mesenchymal and Transformed Properties in Epithelial Cells J. Biol. Chem., November 14, 2003; 278(46): 45801 - 45810. [Abstract] [Full Text] [PDF]

				K. N. Sugahara, T. Murai, H. Nishinakamura, H. Kawashima, H. Saya, and M. Miyasaka Hyaluronan Oligosaccharides Induce CD44 Cleavage and Promote Cell Migration in CD44-expressing Tumor Cells J. Biol. Chem., August 22, 2003; 278(34): 32259 - 32265. [Abstract] [Full Text] [PDF]

				S. Misra, S. Ghatak, A. Zoltan-Jones, and B. P. Toole Regulation of Multidrug Resistance in Cancer Cells by Hyaluronan J. Biol. Chem., July 3, 2003; 278(28): 25285 - 25288. [Abstract] [Full Text] [PDF]